Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hibma

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
The New Zealand Medical Journal|March 3, 2012
Predictors of intent to vaccinate against HPV/cervical cancer: a multi-ethnic survey of 769 parents in New ZealandSally B Rose, Beverley A Lawton, Tolotea S Lanumata, et al.
Clinical Pharmacokinetics|March 12, 2026
Population Pharmacokinetic Modeling of Encorafenib in Healthy Participants and Patients with BRAF V600-Mutant Solid Tumors: A Semi-mechanistic Autoinduction ModelDerek Z Yang, Erik M Hahn, Joseph Piscitelli, et al.
Clinical Pharmacology and Therapeutics|March 31, 2022
Response to "Lorlatinib Exposed: A Far from Optimal Dose"Joseph Chen, Ana Ruiz-Garcia, Leonard P James, et al.
Clinical Pharmacology and Therapeutics|April 24, 2021
Clinical Pharmacology Worldwide: A Global Health PerspectiveLarissa Wenning, Goonaseelan Colin Pillai, Todd C Knepper, et al.
Clinical Pharmacology and Therapeutics|May 11, 2021
Lorlatinib Exposure-Response Analyses for Safety and Efficacy in a Phase I/II Trial to Support Benefit-Risk Assessment in Non-Small Cell Lung CancerJoseph Chen, Ana Ruiz-Garcia, Leonard P James, et al.
Parasite Immunology|March 13, 2012
Delivery of Echinococcus granulosus antigen EG95 to mice and sheep using recombinant vaccinia virusS Dutton, S B Fleming, N Ueda, et al.
Scientific Reports|October 7, 2016
Suppression of the CD8 T cell response by human papillomavirus type 16 E7 occurs in Langerhans cell-depleted miceK Jemon, C-M Leong, K Ly, et al.
Plos One|June 27, 2013
An enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapyKhairunadwa Jemon, Vivienne Young, Michelle Wilson, et al.
Plos One|November 29, 2012
Transcriptional repression of E-cadherin by human papillomavirus type 16 E6Zarina J D'Costa, Carol Jolly, Elliot J Androphy, et al.
Journal of Virology|May 4, 2007
A novel Bcl-2-like inhibitor of apoptosis is encoded by the parapoxvirus ORF virusDana Westphal, Elizabeth C Ledgerwood, Merilyn H Hibma, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
The New Zealand Medical Journal|March 3, 2012
Predictors of intent to vaccinate against HPV/cervical cancer: a multi-ethnic survey of 769 parents in New ZealandSally B Rose, Beverley A Lawton, Tolotea S Lanumata, et al.
Clinical Pharmacokinetics|March 12, 2026
Population Pharmacokinetic Modeling of Encorafenib in Healthy Participants and Patients with BRAF V600-Mutant Solid Tumors: A Semi-mechanistic Autoinduction ModelDerek Z Yang, Erik M Hahn, Joseph Piscitelli, et al.
Clinical Pharmacology and Therapeutics|March 31, 2022
Response to "Lorlatinib Exposed: A Far from Optimal Dose"Joseph Chen, Ana Ruiz-Garcia, Leonard P James, et al.
Clinical Pharmacology and Therapeutics|April 24, 2021
Clinical Pharmacology Worldwide: A Global Health PerspectiveLarissa Wenning, Goonaseelan Colin Pillai, Todd C Knepper, et al.
Clinical Pharmacology and Therapeutics|May 11, 2021
Lorlatinib Exposure-Response Analyses for Safety and Efficacy in a Phase I/II Trial to Support Benefit-Risk Assessment in Non-Small Cell Lung CancerJoseph Chen, Ana Ruiz-Garcia, Leonard P James, et al.
Parasite Immunology|March 13, 2012
Delivery of Echinococcus granulosus antigen EG95 to mice and sheep using recombinant vaccinia virusS Dutton, S B Fleming, N Ueda, et al.
Scientific Reports|October 7, 2016
Suppression of the CD8 T cell response by human papillomavirus type 16 E7 occurs in Langerhans cell-depleted miceK Jemon, C-M Leong, K Ly, et al.
Plos One|June 27, 2013
An enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapyKhairunadwa Jemon, Vivienne Young, Michelle Wilson, et al.
Plos One|November 29, 2012
Transcriptional repression of E-cadherin by human papillomavirus type 16 E6Zarina J D'Costa, Carol Jolly, Elliot J Androphy, et al.
Journal of Virology|May 4, 2007
A novel Bcl-2-like inhibitor of apoptosis is encoded by the parapoxvirus ORF virusDana Westphal, Elizabeth C Ledgerwood, Merilyn H Hibma, et al.
Pageof 12